Diagnostic Biomarkers for Pediatric Acute Pancreatitis

Serum Lipase

The World Journal of Emergency Surgery recommends serum lipase as the primary diagnostic biomarker for pediatric acute pancreatitis, demonstrating superior performance over all other markers 1
Lipase rises within 4-8 hours of pancreatic injury, peaks at 24 hours, and remains elevated for 8-14 days, providing a larger diagnostic window than other markers 1, 2
The diagnostic threshold for lipase is ≥3 times the upper limit of normal, which is most consistent with acute pancreatitis 3, 4
Lipase has higher specificity (89%) and sensitivity (79%) compared to amylase in general populations 1

Amylase rises within 6-24 hours, peaks at 48 hours, but normalizes within 3-7 days, providing a shorter diagnostic window than lipase 1, 2
Amylase has lower sensitivity (72%) and specificity (93%) compared to lipase in general populations 1
Amylase can be elevated in numerous non-pancreatic conditions, including renal disease, appendicitis, acute cholecystitis, bowel obstruction, head injuries, and hepatic injuries 4, 2

Urine trypsinogen-2 dipstick testing offers a rapid, non-invasive bedside alternative with 82% sensitivity and 94% specificity for acute pancreatitis 1
Trypsinogen concentrations rise to high levels within a few hours and decrease within 3 days 1

No laboratory test, including serial enzyme measurements, is consistently accurate for predicting severity in acute pancreatitis 1, 4
C-reactive protein ≥150 mg/L at day 3 can predict severe acute pancreatitis (not for diagnosis) 3
Hematocrit >44% represents an independent risk factor for pancreatic necrosis 3
Procalcitonin is the most sensitive test for detecting pancreatic infection, not for initial diagnosis 3

Enzyme elevation severity does not correlate with disease severity, and a patient with lipase 4x normal can have severe pancreatitis while another with 20x normal may have mild disease 4, 2
Laboratory testing combined with imaging performs no better than lipase alone for diagnosis in children 4

In the absence of gallstones or significant alcohol history, measure serum triglyceride and calcium levels 3, 4
Triglyceride levels >11.3 mmol/L (>1000 mg/dL) indicate hypertriglyceridemia as the etiology 3, 1, 4

Elevated trypsinogen levels, particularly urinary trypsinogen activation peptide (TAP), are most strongly associated with acute pancreatitis and serve as an early marker for disease severity and pancreatic necrosis 5, 6, 7
The American Gastroenterological Association recommends using urinary TAP measurement for early identification of severe acute pancreatitis within 48 hours of symptom onset 5, 6, 7
Urinary TAP has acceptable sensitivity (82%) and high specificity (94%) for acute pancreatitis diagnosis 6, 7
TAP is superior to C-reactive protein for early severity prediction, as it increases earlier than CRP 6, 7

Serum trypsinogen is the most useful of the three serum enzymes (compared to lipase and amylase) for assessing pancreatic function 8
Abnormally low serum enzymes are found in only 50% of patients with pancreatic insufficiency 8
Pancreatic disease must be very advanced (>90% acinar tissue destruction) before serum enzyme concentrations become significantly reduced 8

Elevated TAP in patients with pancreatic necrosis indicates higher risk for infected necrosis 6, 7
The European Society of Gastrointestinal Endoscopy recommends against relying on serum trypsinogen for diagnosing pancreatic insufficiency or chronic pancreatitis, as sensitivity is poor 8